Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is a comparative, open label, parallel group, non interventional study to further
demonstrate the effectiveness and tolerability of Ectoin® Rhinitis Nasal Spray. In addition
the effectiveness and safety shall be compared to a Sinupret forte. The patient applies
Ectoin® Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use.
The observation takes place over a period of 14 days. Response to treatment is recorded at
day 7 and day 14 by the physician and in daily by the patient in a dairy.